🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Participants with Ovarian, Fallopian Tube, or Peritoneal Cancer that has re...
Status
Terminated
Location
Massacusetts General Hospital
Start Date
2016-06-15
Trial ID
NCT02661815
Treatments Being Tested
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
The purpose of the study is to find some biomarkers to predict the the adve...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2021-10-01
Trial ID
NCT05055908
Treatments Being Tested
This is an open-label, dose-escalation and dose-expansion study to determin...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-07-05
Trial ID
NCT05238922
Treatments Being Tested
Although several clinical trials provide evidence for efficacy benefit for ...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2021-10-03
Trial ID
NCT05059951
Treatments Being Tested
The purpose of this study is to determine whether Bevacizumab, CPT-11 and C...
Status
Completed
Location
Duke University Health System
Start Date
2009-09
Trial ID
NCT00953121
Treatments Being Tested
The main purpose of this study is to assess the optimum dose of the followi...
Status
Completed
Location
1200.12.4402 Boehringer Ingelheim Investigational Site
Start Date
2007-05
Trial ID
NCT00809133
The purpose of this study is to evaluate the antitumor efficacy of crenolan...
Status
Terminated
Location
Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
Start Date
2011-04
Trial ID
NCT01229644
Treatments Being Tested
This phase II trial studies how well trastuzumab and pertuzumab or bevacizu...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2013-09-24
Trial ID
NCT01959490
Treatments Being Tested